Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 601 AL 615

Cardiovascular Disorders Mediated by Autonomic Nervous System Dysfunction

Khemani P, Mehdirad AA.

Cardiol Rev. 2020 Mar/Apr;28(2):65-72. doi: 10.1097/CRD.0000000000000280.

Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review

Rabiei M, Kashanian S, Samavati SS, Jamasb S, McInnes SJP.

Curr Pharm Biotechnol. 2020;21(5):374-383. doi: 10.2174/1389201020666191203094057.

[Inpatient treatment costs, cost-driving factors and potential reimbursement problems due to fall-related fractures in patients with Parkinson's disease]

Verboket RD, Mühlenfeld N, Woschek M, Marzi I, Pieper M, Zöllner JP, Strzelczyk A, Willems LM.

Chirurg. 2020 May;91(5):421-427. doi: 10.1007/s00104-019-01074-w.

In Vitro Conversion Assays Diagnostic for Neurodegenerative Proteinopathies

Singh S, DeMarco ML.

J Appl Lab Med. 2020 Jan 1;5(1):142-157. doi: 10.1373/jalm.2019.029801.

Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review

Salehpour F, Gholipour-Khalili S, Farajdokht F, Kamari F, Walski T, Hamblin MR, DiDuro JO, Cassano P.

Rev Neurosci. 2020 Apr 28;31(3):269-286. doi: 10.1515/revneuro-2019-0063.

Is Aquatic Therapy Optimally Prescribed for Parkinson's Disease? A Systematic Review and Meta-Analysis

Carroll LM, Morris ME, O'Connor WT, Clifford AM.

J Parkinsons Dis. 2020;10(1):59-76. doi: 10.3233/JPD-191784.

Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy

Lee JY, Jin HK, Bae JS.

BMB Rep. 2020 Jan;53(1):28-34. doi: 10.5483/BMBRep.2020.53.1.278.

The central regulator p62 between ubiquitin proteasome system and autophagy and its role in the mitophagy and Parkinson's disease

Shin WH, Park JH, Chung KC.

BMB Rep. 2020 Jan;53(1):56-63. doi: 10.5483/BMBRep.2020.53.1.283.

Neurofilament Proteins as Prognostic Biomarkers in Neurological Disorders

Lee Y, Lee BH, Yip W, Chou P, Yip BS.

Curr Pharm Des. 2020;25(43):4560-4569. doi: 10.2174/1381612825666191210154535.

Locus coeruleus-norepinephrine: basic functions and insights into Parkinson's disease

Bari BA, Chokshi V, Schmidt K.

Neural Regen Res. 2020 Jun;15(6):1006-1013. doi: 10.4103/1673-5374.270297.

Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson's disease

Seguella L, Sarnelli G, Esposito G.

Neural Regen Res. 2020 Jun;15(6):1037-1038. doi: 10.4103/1673-5374.270308.

Neuropathological findings in a South Korean patient with Perry syndrome

Chung EJ, Kim SJ, Kim EJ, Ahn JW, Huh GY, Cho HJ, Cairns NJ.

Clin Neuropathol. 2020 Mar/Apr;39(2):80-85. doi: 10.5414/NP301180.

Outcome Evaluation of Highly Challenging Balance Training for People With Parkinson Disease: A Multicenter Effectiveness-Implementation Study

Leavy B, Joseph C, Löfgren N, Johansson H, Hagströmer M, Franzén E.

J Neurol Phys Ther. 2020 Jan;44(1):15-22. doi: 10.1097/NPT.0000000000000298.

Evolving concepts on bradykinesia

Bologna M, Paparella G, Fasano A, Hallett M, Berardelli A.

Brain. 2020 Mar 1;143(3):727-750. doi: 10.1093/brain/awz344.

Improvement of oral function and hygiene in Parkinson's disease: A randomised controlled clinical trial

Baram S, Karlsborg M, Bakke M.

J Oral Rehabil. 2020 Mar;47(3):370-376. doi: 10.1111/joor.12924. Epub 2020 Jan 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias